These findings suggested that the lipid metabolism of NAFLD might be regulated by MAP3K4. Therefore, we selected MAP3K4 as the candidate gene for further verification. This evidence concerns the gene MAP3K4 and metabolic dysfunction-associated steatotic liver disease.